{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"CorMedix Inc."},"Symbol":{"label":"Symbol","value":"CRMD"},"Address":{"label":"Address","value":"300 CONNELL DRIVE,SUITE 4200, BERKELEY HEIGHTS, New Jersey, 07922, United States"},"Phone":{"label":"Phone","value":"+1 908 517-9500"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical needs."},"CompanyUrl":{"label":"Company Url","value":"https://www.cormedix.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Joseph Todisco","title":"Chief Executive Officer & Director"},{"name":"Tushar Mukherjee","title":"Senior Vice President-Technical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}